Cargando…
Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure
Arterial thrombosis triggers myocardial infarction and is a leading cause of death worldwide. Procoagulant platelets, a subpopulation of activated platelets that expose phosphatidylserine (PS), promote coagulation and occlusive thrombosis. Procoagulant platelets may therefore be a therapeutic target...
Autores principales: | Millington-Burgess, Sarah L., Harper, Matthew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417220/ https://www.ncbi.nlm.nih.gov/pubmed/34480042 http://dx.doi.org/10.1038/s41598-021-97212-8 |
Ejemplares similares
-
2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets
por: Wei, Hao, et al.
Publicado: (2020) -
Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets
por: Wei, Hao, et al.
Publicado: (2018) -
Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011) -
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020) -
Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells
por: Feng, Chenchen, et al.
Publicado: (2017)